Decreases in Circulating Tumor Cells after leronlimab induction were seen in 73% of the patients and associated with increase in...
PetVivo Holdings, Inc. Dr. Ann Zieser Joins PetVivo Holdings, Inc. as Senior Technical Veterinarian MINNEAPOLIS, MN, US, Aug. 25, 2021...
PHILADELPHIA and SHANGHAI, China, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (the “Company”), a women’s oncology company developing...
Initial findings from proof-of-concept trial in patients undergoing bunionectomy support expansion of the study to include 36 additional patientsData from...
- Study to evaluate the safety and tolerability of XRD-0394 in combination with palliative radiation therapy - Major milestone for...
Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac...
A wholly owned subsidiary, Osteoid to focus on its award-winning Invivo solutions and add new capabilities to power the future of digital...
SAN FRANCISCO, Aug. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced positive topline results from WHITNEY, the...
The Company’s Common Shares Are Expected to Begin Trading With New CUSIP and ISIN Numbers on or about August 27,...
-- Study is being led by Cleveland Clinic; designed to evaluate potential benefit of OLINVYK on respiratory, GI, and cognitive...
Second Quarter 2021 Revenue Increases 14.6% to $47.7 million as Compared to the First Quarter 2021 Net Income of $4.8...
Silence Therapeutics to Participate in September Investor Conferences 25 August 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN...
NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
BEYOND / HELLO™ University City to Begin Serving Medical Marijuana Patients in the Culturally Diverse Academic Epicenter of Philadelphia on...
IBT started to recruit infants in Strata A (weight of 500g-749g) in The Connection Study on April 29 2021. Today,...
NIAID has initiated a Phase 3 clinical trial to evaluate the efficacy and safety of hyperimmune globulin products, including Emergent’s...
AUSTIN, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease,...
MS Society of Canada’s campaign to inform federal candidates of priorities important to the multiple sclerosis community is under wayTORONTO,...
FirstSight™ Now Qualifies for Expedited FDA Review Process as a Blood Test for Detection of Advanced Neoplasia (Colorectal Cancer &...
BBS-Bioactive Bone Substitutes Plc’s Company Release August 25th 12.45 p.m. January-June 2021 shortly (comparison period 1-6/2020) Company’s operations have grown...
